OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ginsenoside Rg1 Reduced Microglial Activation and Mitochondrial Dysfunction to Alleviate Depression-Like Behaviour Via the GAS5/EZH2/SOCS3/NRF2 Axis
Junnan Li, Wei Gao, Zhonghui Zhao, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 5, pp. 2855-2873
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Natural Products as Modulators of Nrf2 Signaling Pathway in Neuroprotection
Ignacio Moratilla-Rivera, Marta Sánchez, Jose Antonio Valdés-González, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3748-3748
Open Access | Times Cited: 55

Ginsenoside Rg1: A natural triterpenoid glycoside with promising anti-depressive properties
Yating Wang, Jun-Jie Jiang, Yi Zhang
Food Bioscience (2025), pp. 105940-105940
Closed Access | Times Cited: 2

METTL3 boosts mitochondrial fission and induces cardiac fibrosis by enhancing LncRNA GAS5 methylation
Bin Tu, Kai Song, Yang Zhou, et al.
Pharmacological Research (2023) Vol. 194, pp. 106840-106840
Open Access | Times Cited: 33

Ginsenoside Rg1 alleviates chronic inflammation-induced neuronal ferroptosis and cognitive impairments via regulation of AIM2 - Nrf2 signaling pathway
Liangliang Kong, Yan Liu, Jingwei Li, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118205-118205
Closed Access | Times Cited: 14

Therapeutic Potential of Natural Compounds from Herbs and Nutraceuticals in Alleviating Neurological Disorders: Targeting the Wnt Signaling Pathway
Lei Li, Lin Wang, Lijuan Zhang
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 5, pp. 2411-2433
Closed Access | Times Cited: 10

The microbiota–gut–brain axis and its modulation in the therapy of depression: Comparison of efficacy of conventional drugs and traditional Chinese medicine approaches
Chenchen Bi, Shitian Guo, Shijia Hu, et al.
Pharmacological Research (2022) Vol. 183, pp. 106372-106372
Closed Access | Times Cited: 29

The Nrf2 Pathway in Depressive Disorders: A Systematic Review of Animal and Human Studies
Gabriele Sani, Stella Margoni, Andrea Brugnami, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 817-817
Open Access | Times Cited: 21

Efficacy of ginsenoside Rg1 on rodent models of depression: A systematic review and meta-analysis
Yating Wang, Xiaole Wang, Lei Lan, et al.
Psychopharmacology (2024)
Closed Access | Times Cited: 5

Nanocarrier drug delivery system: promising platform for targeted depression therapy
Xiaoying Feng, Ping Jia, Dingding Zhang
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5

From diagnosis to therapy: The role of LncRNA GAS5 in combatting some cancers affecting women
Chou‐Yi Hsu, Safia Obaidur Rab, Ahmed Hussein Zwamel, et al.
Gene (2025), pp. 149217-149217
Closed Access

Ginsenoside 1 mitigates postoperative cognitive dysfunction by enhancing microglial Aβ clearance through the endo-lysosomal pathway
Jing Xu, Yongchang Zhao, Gang Wang, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114281-114281
Open Access

The Effect of mitochondrial-associated endoplasmic reticulum membranes (MAMs) modulation: New insights into therapeutic targets for depression
Maohui Yang, Xuemei Qin, Xiaojie Liu
Neuroscience & Biobehavioral Reviews (2025), pp. 106087-106087
Closed Access

Suppression of miR-218 promotes SOCS3 expression to alleviate cognitive impairment and white matter injury after chronic cerebral hypoperfusion
Yuanyuan Zhu, Juan Tong, Jianzhong Jiang, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access

Biology of cyclooxygenase-2: An application in depression therapeutics
Ying He, Yuanshan Han, Xiaolin Liao, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21

Intranasal Delivery of Mitochondria Attenuates Brain Injury by AMPK and SIRT1/PGC-1α Pathways in a Murine Model of Photothrombotic Stroke
Mohd Salman, Amanda S. Stayton, Kehkashan Parveen, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2822-2838
Closed Access | Times Cited: 10

Ginsenoside Rg1 ameliorates depressive-like behavior by inhibiting NLRP3 inflammasome activation in mice exposed to chronic stress
Hui He, Xiaofang Xie, Xixi Kang, et al.
European Journal of Pharmacology (2023) Vol. 960, pp. 176120-176120
Open Access | Times Cited: 9

Targeting autophagy to counteract neuroinflammation: A novel antidepressant strategy
Hua Gan, Qingyu Ma, Wenzhi Hao, et al.
Pharmacological Research (2024) Vol. 202, pp. 107112-107112
Open Access | Times Cited: 3

Bridging the gap: Integrating exercise mimicry into chronic disease management through suppressing chronic inflammation
Mohammad Nasb, Fengxing Li, L Dayoub, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3

Apoptosis-induced decline in hippocampal microglia mediates the development of depression-like behaviors in adult mice triggered by unpredictable stress during adolescence
Hao‐Jie Zhu, Hainan Pan, Yunli Fang, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176763-176763
Closed Access | Times Cited: 3

Sijunzi decoction enhances sensitivity of colon cancer cells to NK cell destruction by modulating P53 expression
Xinxin Wang, Shufang Pan, Liangyan Chen, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118115-118115
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top